The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Cell Toxicity Induced by Inhibition of Acyl Coenzyme A:Cholesterol Acyltransferase and Accumulation of Unesterified Cholesterol
Open accessAbstract
Considerable evidence supports the involvement of acyl-CoA:cholesterol acyltransferase (ACAT) in the maintenance of intracellular cholesterol homeostasis. A number of recently developed ACAT inhibitors may have potential use as pharmacological agents to reduce the development of atherosclerosis. Recently, however, reports arose describing cytotoxic effects following administration of a specific ACAT inhibitor to experimental animals. In order to address the specific intracellular mechanisms involved with the cytotoxic effect, we examined the consequences of ACAT inhibition in cholesterol-enriched mouse peritoneal macrophages. Mouse peritoneal macrophages were cholesterol-enriched by incubation with acetylated low density lipoprotein and free cholesterol:phospholipid dispersions prior to the addition of an ACAT inhibitor, either Sandoz 58-035 or Pfizer CP-113,818. The adenine pool of the macrophages was radiolabeled prior to addition of the ACAT inhibitors, in order to monitor the release of radiolabeled adenine, a technique shown to be a sensitive method to monitor drug-induced toxicity. The ACAT inhibitors were added for up to 48 h and at concentrations up to 2 micrograms/ml. These conditions resulted in an approximately 2-fold increase in adenine release. The increase in cell toxicity paralleled an increase in the cellular free cholesterol content. Reducing the cellular free cholesterol content, by the addition of extracellular acceptors, decreased the cytotoxic effects of the ACAT inhibitors. Addition of an intracellular cholesterol transport inhibitor, either progesterone or U18666A, together with CP-113,818 blocked the toxic effect of CP-113,818. These results suggest that ACAT inhibition of cholesterol-enriched macrophages increases cell toxicity due to the buildup of cellular free cholesterol. Removal of free cholesterol by the addition of extracellular cholesterol acceptors or by blocking intracellular sterol transport relieves the ACAT inhibitor-induced toxicity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 317,331
Markwell, M. A. K., Haas, S. M., Bieber, L. L., & Tolbert, N. E. (1978) · Analytical Biochemistry · doi:10.1016/0003-2697(78)90586-9 · Cited by 6,458
LIPOPROTEIN METABOLISM IN THE MACROPHAGE: Implications for Cholesterol Deposition in Atherosclerosis
Brown, M. S., & Goldstein, J. L. (1983) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.52.070183.001255 · Cited by 2,300
[19] Receptor-mediated endocytosis of low-density lipoprotein in cultured cells
Goldstein, J. L., Basu, S. K., & Brown, M. S. (1983) · Methods in Enzymology · doi:10.1016/0076-6879(83)98152-1 · Cited by 1,624
HATCH, F. T., & LEES, R. S. (1968) · Advances in Lipid Research · doi:10.1016/b978-1-4831-9942-9.50008-5 · Cited by 1,234
Basu, S. K., Goldstein, J. L., Anderson, G. W., & Brown, M. S. (1976) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.73.9.3178 · Cited by 1,021
Brown, B. G., Zhao, X. Q., Sacco, D. E., & Albers, J. J. (1993) · Circulation · doi:10.1161/01.cir.87.6.1781 · Cited by 821
Brown, M. S., Ho, Y. K., & Goldstein, J. L. (1980) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)70568-7 · Cited by 722
Reversible accumulation of cholesteryl esters in macrophages incubated with acetylated lipoproteins.
Brown, M. S., Goldstein, J. L., Krieger, M., Ho, Y. K., & Anderson, R. G. (1979) · The Journal of cell biology · doi:10.1083/jcb.82.3.597 · Cited by 552
Atherosclerotic plaque caps are locally weakened when macrophages density is increased
Lendon, C. L., Davies, M. J., Born, G. V. R., & Richardson, P. D. (1991) · Atherosclerosis · doi:10.1016/0021-9150(91)90235-u · Cited by 547
Cited by
Mitochondrial Dysfunction in Atherosclerosis
Madamanchi, N. R., & Runge, M. S. (2007) · Circulation Research · doi:10.1161/01.res.0000258450.44413.96 · Cited by 797
Use of cyclodextrins for manipulating cellular cholesterol content
Christian, A. E., Haynes, M. P., Phillips, M. C., & Rothblat, G. H. (1997) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)34940-3 · Cited by 754
Self-citationConsequences of cellular cholesterol accumulation: basic concepts and physiological implications
Tabas, I. (2002) · Journal of Clinical Investigation · doi:10.1172/jci16452 · Cited by 598
Consequences of cellular cholesterol accumulation: basic concepts and physiological implications
Tabas, I. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0216452 · Cited by 540
Duan, Y., Gong, K., Xu, S., Zhang, F., Meng, X., & Han, J. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01125-5 · Cited by 538
Acyl‐coenzyme A:cholesterol acyltransferases
Chang, T.-Y., Li, B.-L., Chang, C. C. Y., & Urano, Y. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90926.2008 · Cited by 443
ACYL-COENZYME A:CHOLESTEROL ACYLTRANSFERASE
Chang, T. Y., Chang, C. C. Y., & Cheng, D. (1997) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.66.1.613 · Cited by 440
Mazzoni, A., Pashley, D. H., Nishitani, Y., Breschi, L., Mannello, F., Tjäderhane, L., Toledano, M., Pashley, E. L., & Tay, F. R. (2006) · Biomaterials · doi:10.1016/j.biomaterials.2006.01.040 · Cited by 431
Cellular Metabolism and Macrophage Functional Polarization
Zhu, L., Zhao, Q., Yang, T., Ding, W., & Zhao, Y. (2015) · International Reviews of Immunology · doi:10.3109/08830185.2014.969421 · Cited by 428
Effect of ACAT Inhibition on the Progression of Coronary Atherosclerosis
Nissen, S. E., Tuzcu, E. M., Brewer, H. B., Sipahi, I., Nicholls, S. J., Ganz, P., Schoenhagen, P., Waters, D. D., Pepine, C. J., Crowe, T. D., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054699 · Cited by 398
Chinetti-Gbaguidi, G., Baron, M., Bouhlel, M. A., Vanhoutte, J., Copin, C., Sebti, Y., Derudas, B., Mayi, T., Bories, G., Tailleux, A., et al. (2011) · Circulation Research · doi:10.1161/circresaha.110.233775 · Cited by 387
Oelkers, P., Behari, A., Cromley, D., Billheimer, J. T., & Sturley, S. L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.41.26765 · Cited by 373
Abrogating cholesterol esterification suppresses growth and metastasis of pancreatic cancer
Li, J., Gu, D., Lee, S. S.-Y., Song, B., Bandyopadhyay, S., Chen, S., Konieczny, S. F., Ratliff, T. L., Liu, X., Xie, J., et al. (2016) · Oncogene · doi:10.1038/onc.2016.168 · Cited by 297
Intracellular cholesterol transport
Fielding, C. J., & Fielding, P. E. (1997) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37169-8 · Cited by 289
Sterol Esterification in Yeast: A Two-Gene Process
Yang, H., Bard, M., Bruner, D. A., Gleeson, A., Deckelbaum, R. J., Aljinovic, G., Pohl, T. M., Rothstein, R., & Sturley, S. L. (1996) · Science · doi:10.1126/science.272.5266.1353 · Cited by 275
Mitochondria-associated ER membranes in Alzheimer disease
Schon, E. A., & Area-Gomez, E. (2013) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2012.07.011 · Cited by 261
Roles of acyl-coenzyme A : cholesterol acyltransferase-1 and -2
Chang, T.-Y., Chang, C. C. Y., Lin, S., Yu, C., Li, B.-L., & Miyazaki, A. (2001) · Current Opinion in Lipidology · doi:10.1097/00041433-200106000-00008 · Cited by 253
Ostermeyer, A. G., Paci, J. M., Zeng, Y., Lublin, D. M., Munro, S., & Brown, D. A. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.152.5.1071 · Cited by 253
Bryleva, E. Y., Rogers, M. A., Chang, C. C. Y., Buen, F., Harris, B. T., Rousselet, E., Seidah, N. G., Oddo, S., LaFerla, F. M., Spencer, T. A., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0913828107 · Cited by 209
Efficient Phagocytosis Requires Triacylglycerol Hydrolysis by Adipose Triglyceride Lipase
Chandak, P. G., Radović, B., Aflaki, E., Kolb, D., Buchebner, M., Fröhlich, E., Magnes, C., Sinner, F., Haemmerle, G., Zechner, R., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.107854 · Cited by 163
LaPensee, C. R., Mann, J. E., Rainey, W. E., Crudo, V., Hunt, S. W., & Hammer, G. D. (2016) · Endocrinology · doi:10.1210/en.2015-2052 · Cited by 86
Pharmacology of the AC AT Inhibitor Avasimibe (CI‐1011)
Llaverías, G., Laguna, J. C., & Alegret, M. (2003) · Cardiovascular Drug Reviews · doi:10.1111/j.1527-3466.2003.tb00104.x · Cited by 77
Cui, D., Thorp, E., Li, Y., Wang, N., Yvan-Charvet, L., Tall, A. R., & Tabas, I. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0307192 · Cited by 73
“ACs deliver to the phagocytes large amounts of membrane cholesterol, which can be cytotoxic if not handled properly [3–5].”
BackgroundFujiyoshi, M., Ohtsuki, S., Hori, S., Tachikawa, M., & Terasaki, T. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04240.x · Cited by 56
Cytotoxic cellular cholesterol is selectively removed by apoA-I via ABCA1
Kellner-Weibel, G. (2003) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2003.08.024 · Cited by 38
Acyl-coenzyme a: cholesterol acyltransferase inhibition in cancer treatment
ZABIELSKA, J., SLEDZINSKI, T., & STELMANSKA, E. (2019) · Anticancer Research · doi:10.21873/anticanres.13482 · Cited by 35
Rodriguez, A., & Usher, D. C. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(01)00620-7 · Cited by 27
Robertson, D. G. (2001) · Toxicological Sciences · doi:10.1093/toxsci/59.2.324 · Cited by 27
Xu, X., Zhang, A., Li, N., Li, P.-L., & Zhang, F. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000430365 · Cited by 27
An, S., Jang, Y.-S., Park, J.-S., Kwon, B.-M., Paik, Y.-K., & Jeong, T.-S. (2008) · Experimental and Molecular Medicine · doi:10.3858/emm.2008.40.4.407 · Cited by 19
Metadata
- Authors
- Stoudt, G., Bamberger, M., Warner, G. J., Johnson, W. J., & Rothblat, G. H.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1995-03
- Volume
- 270
- Issue
- 11
- Pages
- 5772-5778
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2081467822
- Cited by
- 261
- References
- 37
- FWCI
- 10.41
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.